AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Patents For First AIDS Vaccine Specifically Designed For Africa Will Be Jointly Owned.(Brief Article)
2001 SEP 12 - (NewsRx.com & NewsRx.net) --
The partners involved in developing and testing the first HIV/AIDS vaccine specifically designed for an African strain of the disease have agreed to joint ownership of the drug's patents.
Francis Gichaga, vice chancellor of the University of Nairobi, and Seth Berkley, president of the New York-based International AIDS Vaccine Initiative, signed the three-year agreement on August 25, 2001. The third partner, Britain's Medical Research Council, signed the agreement in England that same week.
The groups have been working together since November 1998 to develop a vaccine to combat the viral strain most common in eastern Africa, but wrangles over the ownership and patent rights came to light when testing was set to begin, delaying trials in Kenya. The main concerns appeared to come from the Kenyans.
"This was a delicate matter, requiring a lot of patience and compromise from all parties. The task force was guided by the principle of fairness, equal partnership, and need to equitably apportion credit and any revenues that may accrue from this project," Gichaga said.
Basing much of their research on a group of prostitutes from a Nairobi slum who appear to be immune to HIV, the scientists have developed a double vaccine. The first component is a simple DNA vaccine, which delivers the genetic information on HIV. The second component, known as MVA, is a vaccine that delivers the same genetic information, but uses a weakened smallpox virus to carry it to the cells.
The DNA vaccine is in its first phase of testing on both Kenyans and Britons. Tests of the MVA vaccine are ...
- Advocacy group applauds G8 inclusion of AIDS vaccine as agenda item.
- Newspaper article from: Vaccine Weekly July 7, 2004 700+ words
...to develop a preventive AIDS vaccine. The Enterprise, of...global collaboration in AIDS vaccine research and development...development of a preventive AIDS vaccine. This article was prepared by Vaccine Weekly editors from staff and...
- Global efforts toward AIDS vaccine continue to fall short, according to report.
- Newspaper article from: Vaccine Weekly August 4, 2004 700+ words
...report by the International AIDS Vaccine Initiative (IAVI). IAVI...Accelerating Global Efforts in AIDS Vaccine Research and Development...pledged to expand its own AIDS vaccine research and development...This article was prepared by Vaccine Weekly editors from staff and ...
- Thailand rejects criticism of AIDS vaccine trial.
- Newspaper article from: Vaccine Weekly February 11, 2004 700+ words
...test of a possible AIDS vaccine on thousands of healthy...its pursuit of an AIDS vaccine. Despite those failures...article was prepared by Vaccine Weekly editors from staff...Copyright 2004, Vaccine Weekly via NewsRx.com...
- Distrust may lead blacks to be wary of AIDS vaccine testing.
- Newspaper article from: Vaccine Weekly March 19, 2003 700+ words
...Researchers trying to learn more about why an AIDS vaccine appeared to work well in a small number...the development of an effective HIV/AIDS vaccine," Wilson said. "We need to do a...who participated in VaxGen, Inc.'s AIDS vaccine experiment. The experiment showed that...
- AIDS vaccine to be tested on humans.
- Newspaper article from: Vaccine Weekly April 14, 2004 700+ words
...they will begin human testing of an AIDS vaccine which attacks aggressively the virus...This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx...
- Institute receives $3.5 million for AIDS vaccine research.
- Newspaper article from: Vaccine Weekly June 16, 2004 700+ words
...explore the reasons behind previous AIDS vaccine failures. Additional research collaborators...Center. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx...
- AIDS vaccine developed at Emory, NIH moves to clinical trials.
- Newspaper article from: Vaccine Weekly February 12, 2003 700+ words
...Vaccine Center Director Rafi Ahmed, PhD. "Every new AIDS vaccine candidate that enters human studies brings us closer...manufacture the vaccine. This article was prepared by Vaccine Weekly editors from staff and other reports.
- Experimental AIDS vaccine seen helping some.
- Newspaper article from: Vaccine Weekly March 19, 2003 700+ words
...NewsRx.net) -- A highly anticipated experimental AIDS vaccine failed to protect most people from the disease in its...released later this year. This article was prepared by Vaccine Weekly editors from staff and other reports.
- Synthetic AIDS vaccine targets HIV coreceptors.
- Newspaper article from: Vaccine Weekly February 12, 2003 700+ words
...published the results of their study in Vaccine (Synthetic AIDS vaccine by targeting HIV receptor. Vaccine, 2002;21(1...and HIV and Vaccinology. This article was prepared by Vaccine Weekly editors from staff and other reports.
- "Partially effective" AIDS vaccine may be beneficial.
- Newspaper article from: Vaccine Weekly April 9, 2003 700+ words
...amp; NewsRx.net) -- Even a "partially effective" AIDS vaccine may offer considerable benefits in combating the disease...Disease, and Immunotherapy. This article was prepared by Vaccine Weekly editors from staff and other reports.
Source: HighBeam Research, Patents For First AIDS Vaccine Specifically Designed For Africa Will...